150 related articles for article (PubMed ID: 38244373)
21. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population.
Lee CH; Lin LJ; Cheng CL; Kao Yang YH; Chen JY; Tsai LM
J Thromb Haemost; 2010 Jul; 8(7):1515-23. PubMed ID: 20345707
[TBL] [Abstract][Full Text] [Related]
22. Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis.
Schulman S; Zondag M; Linkins L; Pasca S; Cheung YW; de Sancho M; Gallus A; Lecumberri R; Molnar S; Ageno W; Le Gal G; Falanga A; Hulegårdh E; Ranta S; Kamphuisen P; Debourdeau P; Rigamonti V; Ortel TL; Lee A
J Thromb Haemost; 2015 Jun; 13(6):1010-8. PubMed ID: 25851122
[TBL] [Abstract][Full Text] [Related]
23. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.
Salami A; Qureshi W; Kuriakose P; Moonka D; Yoshida A; Abouljoud M
Transplant Proc; 2013; 45(1):315-9. PubMed ID: 23267811
[TBL] [Abstract][Full Text] [Related]
24. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
[TBL] [Abstract][Full Text] [Related]
25. Description of Venous Thromboembolism in Hospitalized Patients With Metastatic Cancer: A National Sample.
Mohammed KA; Hinyard L; Schoen MW; Geneus CJ; Armbrecht ES; Buckhold FR; Burroughs TE
J Natl Compr Canc Netw; 2018 Feb; 16(2):136-143. PubMed ID: 29439174
[No Abstract] [Full Text] [Related]
26. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study.
Chee CE; Ashrani AA; Marks RS; Petterson TM; Bailey KR; Melton LJ; Heit JA
Blood; 2014 Jun; 123(25):3972-8. PubMed ID: 24782507
[TBL] [Abstract][Full Text] [Related]
27. Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors.
Keegan THM; Li Q; Steele A; Alvarez EM; Brunson A; Flowers CR; Glaser SL; Wun T
Cancer Causes Control; 2018 Jun; 29(6):551-561. PubMed ID: 29654427
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for cancer-associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE-PACC) study.
Douce DR; Holmes CE; Cushman M; MacLean CD; Ades S; Zakai NA
J Thromb Haemost; 2019 Dec; 17(12):2152-2159. PubMed ID: 31423717
[TBL] [Abstract][Full Text] [Related]
29. The occurrence of venous thromboembolism in cancer patients following major surgery.
Toledano TH; Kondal D; Kahn SR; Tagalakis V
Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
[TBL] [Abstract][Full Text] [Related]
30. Hospital-associated venous thromboembolism in children: incidence and clinical characteristics.
Takemoto CM; Sohi S; Desai K; Bharaj R; Khanna A; McFarland S; Klaus S; Irshad A; Goldenberg NA; Strouse JJ; Streiff MB
J Pediatr; 2014 Feb; 164(2):332-8. PubMed ID: 24332452
[TBL] [Abstract][Full Text] [Related]
31. Disparities in the Occurrence of Late Effects following Treatment among Adolescent and Young Adult Melanoma Survivors.
Gingrich AA; Sauder CAM; Goldfarb M; Li Q; Wun T; Keegan THM
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2195-2202. PubMed ID: 32856613
[TBL] [Abstract][Full Text] [Related]
32. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics.
Paneesha S; McManus A; Arya R; Scriven N; Farren T; Nokes T; Bacon S; Nieland A; Cooper D; Smith H; O'Shaughnessy D; Rose P;
Thromb Haemost; 2010 Feb; 103(2):338-43. PubMed ID: 20024496
[TBL] [Abstract][Full Text] [Related]
33. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.
Naik RP; Streiff MB; Haywood C; Segal JB; Lanzkron S
J Thromb Haemost; 2014 Dec; 12(12):2010-6. PubMed ID: 25280124
[TBL] [Abstract][Full Text] [Related]
34. Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.
Posch F; Riedl J; Reitter EM; Kaider A; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2016 Apr; 115(4):817-26. PubMed ID: 26738412
[TBL] [Abstract][Full Text] [Related]
35. Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Blood Adv; 2021 Oct; 5(20):4102-4111. PubMed ID: 34461633
[TBL] [Abstract][Full Text] [Related]
36. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J
J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575
[TBL] [Abstract][Full Text] [Related]
37. Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors.
Xu X; Chlebowski RT; Shi J; Barac A; Haque R
Breast Cancer Res Treat; 2019 Apr; 174(3):785-794. PubMed ID: 30659431
[TBL] [Abstract][Full Text] [Related]
38. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for venous thromboembolism during pregnancy.
Jensen TB; Gerds TA; Grøn R; Bretler DM; Schmiegelow MD; Andersson C; Azimi A; Gislason G; Torp-Pedersen C; Olesen JB
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1283-91. PubMed ID: 24130063
[TBL] [Abstract][Full Text] [Related]
40. The incidence and risk factors for venous thromboembolism in adolescent and young adult oncology patients.
Hsiao W; Krava E; Wee CP; Chau E; Jaffray J
Pediatr Blood Cancer; 2021 May; 68(5):e28957. PubMed ID: 33624938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
